Mohapatra Nrusingh P, Soni Shilpa, Bell Brian L, Warren Richard, Ernst Robert K, Muszynski Artur, Carlson Russell W, Gunn John S
Center for Microbial Interface Biology, Department of Molecular Biology, Immunology and Medical Genetics, The Ohio State University, 460 W. 12th Avenue, Columbus, OH 43210-1214, USA.
Infect Immun. 2007 Jul;75(7):3305-14. doi: 10.1128/IAI.00351-07. Epub 2007 Apr 23.
Francisella tularensis is a category A agent of biowarfare/biodefense. Little is known about the regulation of virulence gene expression in Francisella spp. Comparatively few regulatory factors exist in Francisella, including those belonging to two-component systems (TCS). However, orphan members of typical TCS can be identified. To determine if orphan TCS members affect Francisella gene expression, a gene encoding a product with high similarity to the Salmonella PmrA response regulator (FTT1557c/FNU0663.2) was deleted in Francisella novicida (a model organism for F. tularensis). The F. novicida pmrA mutant was defective in survival/growth within human and murine macrophage cell lines and was 100% defective in virulence in mice at a dose of up to 10(8) CFU. In addition, the mutant strain demonstrated increased susceptibility to antimicrobial peptide killing, but no differences were observed between the lipid A of the mutant and the parental strain, as has been observed with pmrA mutants of other microbes. The F. novicida pmrA mutant was 100% protective as a single-dose vaccine when challenge was with 10(6) CFU of F. novicida but did not protect against type A Schu S4 wild-type challenge. DNA microarray analysis identified 65 genes regulated by PmrA. The majority of these genes were located in the region surrounding pmrA or within the Francisella pathogenicity island (FPI). These FPI genes are also regulated by MglA, but MglA does not regulate pmrA, nor does PmrA regulate MglA. Thus, the orphan response regulator PmrA is an important factor in controlling virulence in F. novicida, and a pmrA mutant strain is an effective vaccine against homologous challenge.
土拉弗朗西斯菌是生物战/生物防御的A类病原体。关于弗朗西斯菌属中毒力基因表达的调控,人们了解甚少。弗朗西斯菌中存在的调控因子相对较少,包括那些属于双组分系统(TCS)的因子。然而,可以鉴定出典型TCS的孤儿成员。为了确定孤儿TCS成员是否影响弗朗西斯菌的基因表达,在新凶手弗朗西斯菌(土拉弗朗西斯菌的一种模式生物)中删除了一个编码与沙门氏菌PmrA应答调节因子具有高度相似性的产物的基因(FTT1557c/FNU0663.2)。新凶手弗朗西斯菌pmrA突变体在人和鼠巨噬细胞系中的存活/生长存在缺陷,在高达10⁸CFU的剂量下对小鼠的毒力有100%的缺陷。此外,突变菌株对抗菌肽杀伤的敏感性增加,但在突变体和亲本菌株的脂多糖之间未观察到差异,这与其他微生物的pmrA突变体情况相同。当用10⁶CFU的新凶手弗朗西斯菌进行攻击时,新凶手弗朗西斯菌pmrA突变体作为单剂量疫苗具有100%的保护作用,但不能抵御A类舒氏S4野生型菌株的攻击。DNA微阵列分析鉴定出65个受PmrA调控的基因。这些基因中的大多数位于pmrA周围区域或弗朗西斯菌致病岛(FPI)内。这些FPI基因也受MglA调控,但MglA不调控pmrA,PmrA也不调控MglA。因此,孤儿应答调节因子PmrA是控制新凶手弗朗西斯菌毒力的一个重要因素,并且pmrA突变体菌株是针对同源攻击的有效疫苗。